Clinical Trials Directory

Trials / Terminated

TerminatedNCT02570139

Clinical Study to Assess a New Barrier Film's Ability to Provide Skin Protection Against Incontinence & Allow Healing

Multi-Center, Randomized Trial Comparing the Efficacy of 3M™ Cavilon™ Advanced Barrier Film for the Treatment of Incontinence-associated Dermatitis to a Commercially Available Moisture Barrier

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Solventum US LLC · Industry
Sex
All
Age
1 Hour
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the safety and efficacy of the investigational product (3M™ Cavilon™ Advanced High Endurance Skin Protectant) for the treatment of incontinence associated dermatitis.

Detailed description

The purpose of this study is to evaluated the product performance of a new skin protectant formulated to protect damaged and denuded skin even in the presence of exposure to the most potentially damaging body fluids, such as liquid stool and gastric fluid. The product is expected to intimately adhere to damaged and denuded skin and provide better protection from further damage than commonly used products such as moisture barrier pastes, thereby making it easier for nursing staff to cleanse the skin after incontinence episodes, thus saving time and also materials. The denuded sites on buttocks/thighs will be scored for skin loss and degree of redness. Over the course of time, with the skin protected, it should re-epithelizes. The skin improvement will be scored and the change in baseline over time monitored.

Conditions

Interventions

TypeNameDescription
DEVICECavilon Advanced Skin ProtectantThe liquid barrier film flows from the applicator and dries quickly on the skin. It is durable for 72-96 hours under conditions of incontinence.
DEVICEConvaTec Sensi-Care Protective BarrierSensi-Care is commercial paste product applied to protect denuded and weeping skin from incontinence.

Timeline

Start date
2015-10-01
Primary completion
2017-06-23
Completion
2017-06-23
First posted
2015-10-07
Last updated
2024-10-02
Results posted
2018-10-12

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02570139. Inclusion in this directory is not an endorsement.